These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36756155)

  • 1. Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA.
    Zhao J; Mu X; Hou X; Zhang X; Li P; Jiang J
    Front Oncol; 2023; 13():1111855. PubMed ID: 36756155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
    Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Reprogramming Armed Macrophage Membrane-Camouflaged Nanoplatform Enhances Bionic Targeted Drug Delivery to Solid Tumor for Synergistic Therapy.
    Ning P; Yao H; Du F; Yuan J; Xia Y; Yang P; Chen X; Rao Z; Wang X
    Mol Pharm; 2023 May; 20(5):2362-2375. PubMed ID: 36989419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
    Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable poly(D,L-lactide-co-glycolide)/poly(L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin.
    Jaimes-Aguirre L; Morales-Avila E; Ocampo-García BE; Medina LA; López-Téllez G; Gibbens-Bandala BV; Izquierdo-Sánchez V
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():743-751. PubMed ID: 28482586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells.
    Niu G; Yousefi B; Qujeq D; Marjani A; Asadi J; Wang Z; Mir SM
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111554. PubMed ID: 33321618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of doxorubicin and siRNA by all-trans retinoic acid conjugated chitosan-based nanocarriers for multiple synergistic antitumor efficacy.
    Liu C; Tang C; Yin C
    Carbohydr Polym; 2022 May; 283():119097. PubMed ID: 35153031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
    Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma.
    Zhang X; Zhao L; Zhai G; Ji J; Liu A
    Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia Inhibitor Combined with Chemotherapeutic Agents for Antitumor and Antimetastatic Efficacy against Osteosarcoma.
    Zhao TT; Zhou TJ; Zhang C; Liu YX; Wang WJ; Li C; Xing L; Jiang HL
    Mol Pharm; 2023 May; 20(5):2612-2623. PubMed ID: 37042832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer.
    Hu F; Zhang R; Guo W; Yan T; He X; Hu F; Ren F; Ma X; Lei J; Zheng W
    Mol Pharm; 2021 Jun; 18(6):2161-2173. PubMed ID: 32515968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
    Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
    Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers.
    Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T
    Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.